Effect of New Oral Anticoagulants Dabigatran and Rivaroxaban on Point of Care Coagulation Testing - an Ex-Vivo Study
NCT01704053
·
clinicaltrials.gov ↗
COMPLETED
Status
34
Enrollment
OTHER
Sponsor class
Conditions
Clot Formation and Platelet Aggregation in Point of Care Testing
Sponsor
Johann Wolfgang Goethe University Hospital